Literature DB >> 12700765

Coordinated histone modifications mediated by a CtBP co-repressor complex.

Yujiang Shi1, Jun-ichi Sawada, Guangchao Sui, El Bachir Affar, Johnathan R Whetstine, Fei Lan, Hidesato Ogawa, Margaret Po-Shan Luke, Yoshihiro Nakatani, Yang Shi.   

Abstract

The transcriptional co-repressor CtBP (C-terminal binding protein) is implicated in tumorigenesis because it is targeted by the adenovirus E1A protein during oncogenic transformation. Genetic studies have also identified a crucial function for CtBP in animal development. CtBP is recruited to DNA by transcription factors that contain a PXDLS motif, but the detailed molecular events after the recruitment of CtBP to DNA and the mechanism of CtBP function in tumorigenesis are largely unknown. Here we report the identification of a CtBP complex that contains the essential components for both gene targeting and coordinated histone modifications, allowing for the effective repression of genes targeted by CtBP. Inhibiting the expression of CtBP and its associated histone-modifying activities by RNA-mediated interference resulted in alterations of histone modifications at the promoter of the tumour invasion suppressor gene E-cadherin and increased promoter activity in a reporter assay. These findings identify a molecular mechanism by which CtBP mediates transcriptional repression and provide insight into CtBP participation in oncogenesis.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12700765     DOI: 10.1038/nature01550

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  335 in total

Review 1.  Functional Crosstalk Between Lysine Methyltransferases on Histone Substrates: The Case of G9A/GLP and Polycomb Repressive Complex 2.

Authors:  Chiara Mozzetta; Julien Pontis; Slimane Ait-Si-Ali
Journal:  Antioxid Redox Signal       Date:  2014-12-19       Impact factor: 8.401

2.  Smad6 recruits transcription corepressor CtBP to repress bone morphogenetic protein-induced transcription.

Authors:  Xia Lin; Yao-Yun Liang; Baohua Sun; Min Liang; Yujiang Shi; F Charles Brunicardi; Yang Shi; Xin-Hua Feng
Journal:  Mol Cell Biol       Date:  2003-12       Impact factor: 4.272

3.  Functional similarity of Knirps CtBP-dependent and CtBP-independent transcriptional repressor activities.

Authors:  Jae-Ryeon Ryu; David N Arnosti
Journal:  Nucleic Acids Res       Date:  2003-08-01       Impact factor: 16.971

4.  Histone modifications: Now summoning sumoylation.

Authors:  Dafna Nathan; David E Sterner; Shelley L Berger
Journal:  Proc Natl Acad Sci U S A       Date:  2003-11-03       Impact factor: 11.205

5.  CtBP contributes quantitatively to Knirps repression activity in an NAD binding-dependent manner.

Authors:  Montserrat Sutrias-Grau; David N Arnosti
Journal:  Mol Cell Biol       Date:  2004-07       Impact factor: 4.272

6.  Chromatin modification of Notch targets in olfactory receptor neuron diversification.

Authors:  Keita Endo; M Rezaul Karim; Hiroaki Taniguchi; Alena Krejci; Emi Kinameri; Matthias Siebert; Kei Ito; Sarah J Bray; Adrian W Moore
Journal:  Nat Neurosci       Date:  2011-12-25       Impact factor: 24.884

Review 7.  Evolutionary functional analysis and molecular regulation of the ZEB transcription factors.

Authors:  Alexander Gheldof; Paco Hulpiau; Frans van Roy; Bram De Craene; Geert Berx
Journal:  Cell Mol Life Sci       Date:  2012-02-21       Impact factor: 9.261

Review 8.  An epigenetic perspective on the free radical theory of development.

Authors:  Michael J Hitchler; Frederick E Domann
Journal:  Free Radic Biol Med       Date:  2007-07-10       Impact factor: 7.376

9.  ZEB-1, a repressor of the semaphorin 3F tumor suppressor gene in lung cancer cells.

Authors:  Jonathan Clarhaut; Robert M Gemmill; Vincent A Potiron; Slimane Ait-Si-Ali; Jean Imbert; Harry A Drabkin; Joëlle Roche
Journal:  Neoplasia       Date:  2009-02       Impact factor: 5.715

10.  Role of transcriptional corepressor CtBP1 in prostate cancer progression.

Authors:  Rui Wang; Irfan A Asangani; Balabhadrapatruni V S K Chakravarthi; Bushra Ateeq; Robert J Lonigro; Qi Cao; Ram-Shankar Mani; Daniel F Camacho; Natalie McGregor; Taibriana E W Schumann; Xiaojun Jing; Radhika Menawat; Scott A Tomlins; Heng Zheng; Arie P Otte; Rohit Mehra; Javed Siddiqui; Saravana M Dhanasekaran; Mukesh K Nyati; Kenneth J Pienta; Nallasivam Palanisamy; Lakshmi P Kunju; Mark A Rubin; Arul M Chinnaiyan; Sooryanarayana Varambally
Journal:  Neoplasia       Date:  2012-10       Impact factor: 5.715

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.